Evaluation of lung epithelial lining fluid concentrations of lascufloxacin against Streptococcus pneumoniae in a hollow-fiber infection model

Haruka Nakagawa Kamura, Tetsuo Yamaguchi, Toshihiro Kasama, Yukitaka Hayashi, Masakaze Hamada, Kazuaki Matsumoto, Ryo Miyake, Yoshikazu Ishii · 2025

Read Evaluation of lung epithelial lining fluid concentrations of lascufloxacin against Streptococcus pneumoniae in a hollow-fiber infection model by Haruka Nakagawa Kamura, Tetsuo Yamaguchi, Toshihiro Kasama, Yukitaka Hayashi, Masakaze Hamada, Kazuaki Matsumoto, Ryo Miyake, Yoshikazu Ishii (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w4410112906.txt.

Description

Haruka Nakagawa Kamura, Tetsuo Yamaguchi, Toshihiro Kasama, and colleagues test the antibiotic lascufloxacin against pneumonia bacteria. Their paper appeared in The Journal of Antibiotics in 2025. The drug gathers in lung lining fluid at levels far above those in blood. That buildup could make it strong against lung infections.

The team recreated those lung fluid levels in a hollow-fibre infection model. The model simulates drug exposure and bacterial growth under controlled conditions. At those levels, the drug killed the pneumonia bacterium. It killed both normal strains and strains resistant to levofloxacin. The results confirm that the high lung levels drive the drug's killing power.

Catalog record

CREATORHaruka Nakagawa Kamura, Tetsuo Yamaguchi, Toshihiro Kasama, Yukitaka Hayashi, Masakaze Hamada, Kazuaki Matsumoto, Ryo Miyake, Yoshikazu Ishii
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE18 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEOpenAlex / The Journal of Antibiotics

Source: https://doi.org/10.1038/s41429-025-00826-7

Browse the full library · About the Tower of Babel